EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Capture of Longitudinal Change in Real‐Life Walking in Cerebellar Ataxia Increases Patient Relevance and Effect Size

Jens Seemann, Theresa Beyme, Natalie John, Florian Harmuth, Martin Giese, Ludger Schöls, Dagmar Timmann, Matthis Synofzik iD, Winfried Ilg iD

Movement Disorders · 2025-07 · 40 (7) · 1343-1355

DOI: 10.1002/mds.30230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 21.05.2025. Verfasst von Jens Seemann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section Computational Sensomotorics, Hertie Institute for Clinical Brain Research, Tübingen, Germany. Hauptthemen laut MEDLINE: Cerebellar Ataxia, Walking, Gait Disorders, Neurologic, Gait. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Else Kröner-Fresenius-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

With disease‐modifying drugs for degenerative ataxias on the horizon, ecologically valid measures of gait performance that can detect patient‐relevant changes in trial‐like time frames are highly warranted.

Objectives

In this 2‐year longitudinal study, we aimed to unravel ataxic gait measures sensitive to longitudinal changes in patients' real lives using wearable sensors.

Methods

We assessed longitudinal gait changes of 26 participants with degenerative cerebellar disease (Scale for the Assessment and Rating of Ataxia [SARA]: 9.4 ± 4.1) at baseline, 1‐year, and 2‐year follow‐up using three body‐worn inertial sensors in two conditions: (1) laboratory‐based walking (LBW); and (2) real‐life walking (RLW). In RLW, a context‐sensitive analysis was performed by selecting comparable walking bouts according to macroscopic gait characteristics. Gait analysis focused on measures of spatio‐temporal variability, particularly stride length variability, lateral step deviation, and a compound measure of spatial variability (SPCmp).

Results

Gait variability measures showed high test–retest reliability in both walking conditions (intraclass correlation coefficient [ICC], ≥0.82). Cross‐sectional analyses revealed high correlations of gait measures with ataxia severity (SARA, effect size ρ ≥ 0.75); and with patients' subjective balance confidence (Activity‐specific Balance Confidence scale [ABC]: ρ ≥ 0.71). Although SARA showed longitudinal changes only after 2 years, the gait measure SPCmp revealed changes after 1 year with high effect size ( r prb = 0.80). Sample size estimation for the gait measure SPCmp showed a required cohort size of n = 42 participants (n = 38; spinocerebellar ataxias [SCA] 1/2/3 subgroup) to detect a 50% reduction in progression at 1 year with a hypothetical intervention, compared to n = 147 for SARA at 2 years.

Conclusions

Because of their ecological validity and larger effect sizes, real‐life gait characteristics represent promising performance measures as outcomes for future treatment trials. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebellar AtaxiaWalkingGait Disorders, NeurologicGaitHumansFemaleMaleLongitudinal StudiesMiddle AgedAgedGait AnalysisReproducibility of ResultsDisease Progression

Stichwörter der Autor:innen

biomarkercerebellar ataxiadigital healthreal‐life walkingwearable sensors

Autor:innen und Institutionen

  • Section Computational Sensomotorics, Hertie Institute for Clinical Brain Research, Tübingen, Germany.
  • Centre for Integrative Neuroscience (CIN), Tübingen, Germany.
  • Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center for Neurology, University of Tübingen, Tübingen, Germany.
  • Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, University of Tübingen, Tübingen, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
  • Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and Centre of Neurology, Tübingen, Germany.

ORCID-Profile: Matthis Synofzik, Winfried Ilg

Förderung

  • European Commission
  • Else Kröner-Fresenius-Stiftung

Zitieren

APA

Seemann, J., Beyme, T., John, N., Harmuth, F., Giese, M., Schöls, L., Timmann, D., Synofzik, M., & Ilg, W. (2025). Capture of Longitudinal Change in Real‐Life Walking in Cerebellar Ataxia Increases Patient Relevance and Effect Size. Movement Disorders, 40(7), 1343-1355. https://doi.org/10.1002/mds.30230

Vancouver

Seemann J, Beyme T, John N, Harmuth F, Giese M, Schöls L, et al. Capture of Longitudinal Change in Real‐Life Walking in Cerebellar Ataxia Increases Patient Relevance and Effect Size. Movement Disorders. 2025;40(7):1343-1355. doi:10.1002/mds.30230

BibTeX
@article{Seemann2025,
  author = {Seemann, Jens and Beyme, Theresa and John, Natalie and Harmuth, Florian and Giese, Martin and Schöls, Ludger and Timmann, Dagmar and Synofzik, Matthis and Ilg, Winfried},
  title = {Capture of Longitudinal Change in Real‐Life Walking in Cerebellar Ataxia Increases Patient Relevance and Effect Size},
  journal = {Movement Disorders},
  year = {2025},
  volume = {40},
  number = {7},
  pages = {1343--1355},
  doi = {10.1002/mds.30230}
}
Kostenlos starten →